Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Tsumura

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|November 3, 2023
Checkpoint inhibition in hematologic malignanciesAaron Tsumura, Daniel Levis, Joseph M Tuscano
Frontiers in Oncology|November 6, 2024
Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphomaNaseem Esteghamat, Aaron Tsumura, Gabriel Marquez-Arreguin, et al.
Animal Models and Experimental Medicine|July 3, 2020
Alcohol-induced Wnt signaling inhibition during bone fracture healing is normalized by intermittent parathyroid hormone treatmentEsha M Kapania, Taylor J Reif, Aaron Tsumura, et al.
Oncotarget|December 16, 2014
Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancerIgor Vujic, Martina Sanlorenzo, Christian Posch, et al.
Oncotarget|January 16, 2016
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cellsIgor Vujic, Martina Sanlorenzo, Rosaura Esteve-Puig, et al.
Oncotarget|October 4, 2014
Mutant NRASQ61 shares signaling similarities across various cancer types--potential implications for future therapiesIgor Vujic, Christian Posch, Martina Sanlorenzo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|November 3, 2023
Checkpoint inhibition in hematologic malignanciesAaron Tsumura, Daniel Levis, Joseph M Tuscano
Frontiers in Oncology|November 6, 2024
Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphomaNaseem Esteghamat, Aaron Tsumura, Gabriel Marquez-Arreguin, et al.
Animal Models and Experimental Medicine|July 3, 2020
Alcohol-induced Wnt signaling inhibition during bone fracture healing is normalized by intermittent parathyroid hormone treatmentEsha M Kapania, Taylor J Reif, Aaron Tsumura, et al.
Oncotarget|December 16, 2014
Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancerIgor Vujic, Martina Sanlorenzo, Christian Posch, et al.
Oncotarget|January 16, 2016
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cellsIgor Vujic, Martina Sanlorenzo, Rosaura Esteve-Puig, et al.
Oncotarget|October 4, 2014
Mutant NRASQ61 shares signaling similarities across various cancer types--potential implications for future therapiesIgor Vujic, Christian Posch, Martina Sanlorenzo, et al.
Pageof 1